# corporate%20governance
Latest news and articles about corporate%20governance
Total: 75 articles found
Vanke’s Shadow Network: Middlemen, Billions of Receivables and a Corporate‑Governance Crisis
An investigative report links a network of ‘shadow’ firms tied to Vanke insiders with a string of quick‑turn land and project transfers into the listed group. These arrangements coincide with hundreds of billions of yuan in intercompany receivables and large impairment charges that have substantially worsened Vanke’s financial losses and raised fresh governance questions.
Founder of Buchang Pharmaceuticals Faces Court-Imposed Consumption Ban as Family Hotel Owes RMB 16m
An 84‑year‑old founder of Buchang Pharmaceuticals has been subject to a court‑ordered ban on high‑end consumption after his family‑owned hotel failed to repay a RMB 16 million loan. The enforcement action, though separate from the listed drugmaker, spotlights governance, related‑party risk and the company’s long reliance on marketing over R&D amid a sharply reduced market valuation.
Buchang Pharma Founder Hit with Consumption Ban After Family Hotel Defaults on Rmb16m Loan
An enforcement order has placed Buchang Pharmaceutical founder Zhao Buchang on China’s restricted‑consumption list after a family‑owned hotel failed to fully repay a Rmb16 million loan. The case is legally separate from the listed company but raises governance and related‑party concerns given the Zhao family’s recent local property acquisitions and the founder’s controlling stakes in non‑listed assets.
Chinese Listed Huatu Unit Warned for Hidden Funding and Undisclosed Related‑Party Deals; Subsidiary Fined for Unregistered Publications
Sichuan securities authorities ordered corrective measures and issued warning letters to Huatu Shanding and four senior executives after finding undisclosed financial support for an affiliate and delayed reporting of related‑party transactions totaling about RMB 69 million. A Huatu education subsidiary in Daqing was also fined and had exam materials confiscated for failing to register publications. Regulators recorded the actions in the market integrity database, signalling reputational and compliance risks for the group.
China’s Exchanges Loosen Re‑financing Rules to Back Tech R&D — with New Guardrails
China’s three main stock exchanges have eased refinancing rules to help R&D‑intensive and unprofitable science‑and‑technology firms raise capital more quickly, extended a ‘light‑asset, high‑R&D’ standard to main boards, and streamlined procedures while tightening oversight to prevent misuse. The package is calibrated to sustain long‑term innovation funding while guarding against speculative or control‑seeking abuses.
Family Control, Faulty Toilets and Forced Make‑ups: How Arrow Home’s Governance and ESG Gaps Are Hitting Its Business
Arrow Home, a major Chinese sanitaryware maker, faces mounting reputational and financial strain after consumer complaints, alleged labor‑rights violations and a family‑dominated governance structure exposed weaknesses in its ESG performance. Despite middling Wind ESG ratings and a recent publicity partnership, falling revenues and a dividend plan that exceeds net profit raise questions about the company's long‑term resilience.
Konka's Fall: China’s Once-Dominant TV Maker Posts Billions in Losses and Faces Delisting Risk
Konka, once a leader in China’s television market, warned of a RMB 12.58–15.57 billion net loss for 2025 and faces a likely negative net-asset position and possible delisting. Years of shrinking TV sales, sprawling diversification, mounting impairments and governance lapses have culminated in a balance-sheet crisis that China Resources has begun to address but cannot resolve alone.
China’s Aier Empire Exposed: Psychiatric Hospital Fraud Lifts the Veil on a Hidden Medical Network
Allegations of systematic medical‑insurance fraud at several psychiatric hospitals in Hubei have revealed links to Aier Medical Investment, the non‑listed vehicle controlled by Chen Bang, founder of listed Aier Eye. The case spotlights how opaque ownership layers can shield high‑risk healthcare businesses and raises the prospect of intensified regulatory and market scrutiny across China’s private medical sector.
China’s E‑Paper Champion Faces Regulator’s Scissors: Investigation and Asset Freezes Threaten Qingyue’s Survival
China’s securities regulator has opened a formal investigation into Qingyue Technology over alleged false financial reporting and has frozen key securities and fundraising bank accounts. The probe follows prior warnings about misuse of raised funds, undisclosed related‑party deals and a disputed export‑tax rebate, and raises the spectre of forced delisting amid weak industry conditions and strained company finances.
China’s Securities Regulator Opens Probe Into Listed Firm Yahui Long Over Disclosure Irregularities
Yahui Long said it received a formal CSRC filing notice on 6 February 2026 alleging suspected information-disclosure violations, triggering an official investigation. The move fits a broader regulatory tightening by Chinese authorities aimed at improving market governance and could provoke short-term share-price volatility and closer scrutiny of the company.
Food‑safety warning clouds Ban U hotpot’s Hong Kong IPO push
Nanjing regulators detected excessive bifenthrin residue on oranges served at a Ban U hotpot branch, a finding that collides with the chain's quiet‑period preparations for a Hong Kong IPO. The incident highlights how food‑safety lapses and governance questions can complicate capital‑markets plans for consumer brands in China.
A Fall from Grace: How a Bitter Fight Over Huiyuan Juice Has Left Jiang Zhaobai’s Listed Empire Hanging On
A violent ownership dispute over Beijing Huiyuan has derailed a planned asset injection into Guozhong Water and triggered large impairments that put the company at risk of *ST designation and possible delisting. The turmoil exposes broader weaknesses in the Pengxin group controlled by Jiang Zhaobai — from disputed mining acquisitions and unmet performance guarantees to heavy share pledges and governance lapses — and raises questions about recoverability for creditors and minority shareholders.